BioSpace News Archive

Takeda Initiates Phase I Clinical Trial of Zika Vaccine Candidate

The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 240 subjects between the ages of 18 and 49 across the continental U.S. and U.S. territories.

November 28, 2017

·

8 min read

BioMidwest

Bio-Techne’s RNAscope Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-Ranging Research with over 1000 Publications

Reaching 1,000 publications and increasing to an average of more than one publication per day, papers using RNAscope now feature regularly in top tier journals.

November 28, 2017

·

5 min read

Business

CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix FG for Treatment of Acute and Chronic Wounds and Surgical Cuts

Under the terms of the agreement, the distributor undertook to make the first order for the product when signing the agreement, in an amount that is not material to the Company.

November 28, 2017

·

2 min read

Drug Development

NeuroproteXeon Announces Publication of Xenon Study to Lessen Cardiac Damage Following Out-of-Hospital Cardiac Arrest

NeuroproteXeon announced the publication of a second finding from a randomized, controlled Phase II trial of inhaled xenon and oxygen, combined with hypothermia, for out-of-hospital cardiac arrest patients.

November 28, 2017

·

1 min read

Business

PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call

Management will also discuss the progress made to commercialize its two antimicrobial SDC-based food safety solution.

November 28, 2017

·

4 min read

Drug Development

Regentis Biomaterials Performs the First Cases in Gelrinc Pivotal Study

Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial of GelrinC for the treatment of focal knee cartilage defects with successful surgery on three patients in the U.S. and Denmark.

November 28, 2017

·

3 min read

Pharm Country

Celmatix: The Fertilome Test is the First Multigene Panel Test for Women’s Risk of Reproductive Conditions Approved by the NY State Department of Health

Announced in January 2017, the Fertilome test has already been ordered for numerous women by reproductive specialists and OB-GYNs across the U.S.

November 28, 2017

·

3 min read

Biotech Bay

Bio-Rad Authorizes New $250M Share Repurchase Program

Repurchases may be made at management’s discretion from time to time on the open market or through privately negotiated transactions.

November 28, 2017

·

4 min read

Catalyst Pharma Prices Previously Announced Public Offering of Common Stock

The Company announced that it is selling 14,285,715 shares of its common stock in the public offering at an offering price of $3.50 per share.

November 28, 2017

·

4 min read

Policy

Upsher-Smith Launches KLOR-CON Powder (Potassium Chloride) for Oral Solution

The Company received approval of an ANDA from the FDA for this product, which will be marketed and distributed by Upsher-Smith.

November 28, 2017

·

2 min read